These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 7689605)
21. c-kit mRNA expression in human and murine hematopoietic cell lines. André C; d'Auriol L; Lacombe C; Gisselbrecht S; Galibert F Oncogene; 1989 Aug; 4(8):1047-9. PubMed ID: 2474787 [TBL] [Abstract][Full Text] [Related]
22. Regulation of CD9 expression during 12-O-tetradecanoyl-phorbol-13-acetate- induced differentiation of human myeloid leukemia (HL-60) cells. Xu M; Chen L; Christman JK Cell Growth Differ; 1994 Nov; 5(11):1225-34. PubMed ID: 7848923 [TBL] [Abstract][Full Text] [Related]
23. Effects of interferon-gamma on proto-oncogene expression during induction of human monocytic differentiation. Sariban E; Mitchell T; Griffin J; Kufe DW J Immunol; 1987 Mar; 138(6):1954-8. PubMed ID: 3102606 [TBL] [Abstract][Full Text] [Related]
24. Fos and Jun form cell specific protein complexes at the neuropeptide tyrosine promoter. Jalava A; Mai S Oncogene; 1994 Aug; 9(8):2369-75. PubMed ID: 8036020 [TBL] [Abstract][Full Text] [Related]
25. Loss of c-kit expression in cultured melanoma cells. Lassam N; Bickford S Oncogene; 1992 Jan; 7(1):51-6. PubMed ID: 1371338 [TBL] [Abstract][Full Text] [Related]
26. Multiple mechanisms of regulation of the human c-myb gene during myelomonocytic differentiation. Boise LH; Gorse KM; Westin EH Oncogene; 1992 Sep; 7(9):1817-25. PubMed ID: 1323820 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of Kit expression by IL-4 and IL-10 in murine mast cells: role of STAT6 and phosphatidylinositol 3'-kinase. Mirmonsef P; Shelburne CP; Fitzhugh Yeatman C; Chong HJ; Ryan JJ J Immunol; 1999 Sep; 163(5):2530-9. PubMed ID: 10452990 [TBL] [Abstract][Full Text] [Related]
28. c-myc expression correlates with suppression of c-kit protooncogene expression in small cell lung cancer cell lines. Plummer H; Catlett J; Leftwich J; Armstrong B; Carlson P; Huff T; Krystal G Cancer Res; 1993 Sep; 53(18):4337-42. PubMed ID: 7689933 [TBL] [Abstract][Full Text] [Related]
29. Expression of selected genes and oncogenes in differentiated HL-60 cells and primary cells from human leukemias. Shiosaka T; Tanaka Y Anticancer Res; 1989; 9(5):1249-64. PubMed ID: 2589822 [TBL] [Abstract][Full Text] [Related]
30. Human Harvey-ras is biochemically different from Kirsten- or N-ras. Carbone A; Gusella GL; Radzioch D; Varesio L Oncogene; 1991 May; 6(5):731-7. PubMed ID: 1905005 [TBL] [Abstract][Full Text] [Related]
31. Protein kinase C-dependent release of a functional whole extracellular domain of the mast cell growth factor (MGF) receptor by MGF-dependent human myeloid cells. Brizzi MF; Blechman JM; Cavalloni G; Givol D; Yarden Y; Pegoraro L Oncogene; 1994 Jun; 9(6):1583-9. PubMed ID: 7514283 [TBL] [Abstract][Full Text] [Related]
32. Differential induction of transcription of c-myc and c-fos proto-oncogenes by 12-O-tetradecanoylphorbol-13-acetate in mortal and immortal human urothelial cells. Skouv J; Christensen B; Autrup H J Cell Biochem; 1987 Jun; 34(2):71-9. PubMed ID: 3597558 [TBL] [Abstract][Full Text] [Related]
33. Resistance to phorbol ester-induced differentiation of a U-937 myeloid leukemia cell variant with a signaling defect upstream to Raf-1 kinase. Hass R; Hirano M; Kharbanda S; Rubin E; Meinhardt G; Kufe D Cell Growth Differ; 1993 Aug; 4(8):657-63. PubMed ID: 8398907 [TBL] [Abstract][Full Text] [Related]
34. Induction of met proto-oncogene (hepatocyte growth factor receptor) expression during human monocyte-macrophage differentiation. Chen Q; DeFrances MC; Zarnegar R Cell Growth Differ; 1996 Jun; 7(6):821-32. PubMed ID: 8780895 [TBL] [Abstract][Full Text] [Related]
35. Relationship of cellular oncogene expression to inhibition of growth and induction of differentiation of Daudi cells by interferons or TPA. Clemens MJ; Tilleray VJ; James R; Gewert DR J Cell Biochem; 1988 Dec; 38(4):251-9. PubMed ID: 2467914 [TBL] [Abstract][Full Text] [Related]
36. Absence of immature mast cells in the skin of Ws/Ws rats with a small deletion at tyrosine kinase domain of the c-kit gene. Onoue H; Maeyama K; Nomura S; Kasugai T; Tei H; Kim HM; Watanabe T; Kitamura Y Am J Pathol; 1993 Apr; 142(4):1001-7. PubMed ID: 7682755 [TBL] [Abstract][Full Text] [Related]
37. Cloning of tetradecanoyl phorbol ester-induced 'primary response' sequences and their expression in density-arrested Swiss 3T3 cells and a TPA non-proliferative variant. Lim RW; Varnum BC; Herschman HR Oncogene; 1987; 1(3):263-70. PubMed ID: 3330774 [TBL] [Abstract][Full Text] [Related]
38. PLZF-mediated control on c-kit expression in CD34(+) cells and early erythropoiesis. Spinello I; Quaranta MT; Pasquini L; Pelosi E; Petrucci E; Pagliuca A; Castelli G; Mariani G; Diverio D; Foà R; Testa U; Labbaye C Oncogene; 2009 Jun; 28(23):2276-88. PubMed ID: 19421145 [TBL] [Abstract][Full Text] [Related]
39. Retinoic acid induces down-regulation of several growth factors and proto-oncogenes in a human embryonal cancer cell line. Miller WH; Moy D; Li A; Grippo JF; Dmitrovsky E Oncogene; 1990 Apr; 5(4):511-7. PubMed ID: 2158037 [TBL] [Abstract][Full Text] [Related]
40. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression. Suhasini M; Boss GR; Pascual FE; Pilz RB Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]